BIO Brings Its Expertise & Industry Leaders to China - Bio China International Conference 2011

Bio China 2011

October 12-13, 2011
Pudong Shangri-La Hotel
Shanghai, China

Biotech leaders from around the world are coming to China.
Will you be there to greet them?

Register Now! http://www.bio.org/biochina

Meet the leaders. Understand the issues.
Seek out the opportunities.

BIO® China will bring powerful and influential investors, biotechnology executives, and industry experts to Shanghai in search of partnerships,deals and opportunities.

Biotech companies will have two days to present their work and to schedule numerous private meetings to discuss interests and capabilities. Dinners and informal networking events will give attendees further access to these biotechnology leaders.

Equally important, BIO China features extensive programming on the issues that are vital to the success of your investments and partnerships.

As the industry leader, the Biotechnology Industry Organization (BIO) can attract speakers and panelists with the greatest insight into intellectual property, manufacturing concerns, regulatory issues, cultural differences, and research and drug trial considerations.

BIO brings its professionalism and expertise to China.

BIO is the nonprofit organization that represents the interests of the entire industry. For fifteen years BIO has set the standard for investor and partnering conferences in North America, Europe and Asia.

Each year BIO hosts the BIO International Convention, attracting thousands of CEOs and top executives to the industry’s largest meeting and must-attend event. It includes the Business Forum, the biggest partnering event in the world.

Now BIO China focuses this same degree of professionalism and expertise on the emerging biotech industry in China.

BIO China 2011 will feature

      • BIO One-on-One PartneringTM: Use BIO’s proprietary partnering software to efficiently find and meet with potential strategic business partners.

      • Plenary Sessions and Policy & Business Development Workshops: Hear from speakers and panelists with the greatest insights into manufacturing concerns, regulatory issues, cultural differences, research and drug trial considerations, and intellectual property concerns.

      • Company Presentations: Present your story to an audience of key industry executives interested in your company.

      • Exhibit Hall: Showcase your company to senior-level executives.

      • Networking Opportunities: Participate in formal and informal networking opportunities, including luncheons and a gala reception.

Registration and Hotel Information

Early Registration Ends September 8, 2011. Register now at bio.org/biochina.

Early Registration: ¥ 4,100/ US $599
Late Registration: ¥ 6,100/ US $890
Presenting Companies: ¥ 6,500/ US $949
Investors: $595
Hotel Information: Pudong Shangri-La Hotel, 33 Fu Cheng Rd., Pudong, Shanghai 200120, China

Program

Health & Regulatory

1. Conducting Pre-Clinical Studies in China
This session will explore opportunities for conducting pre-clinical work in China.

2. Challenges and Opportunities for Clinical Development in China
Seasoned representatives from major CROs and drug development companies will discuss site selection, IRB approval processes, and content requirements for Clinical Trial Applications to initiate trials in China.

3. Manufacturing in China
This session will provide the audience the opportunity to ask industry manufacturing executives from multi-national companies about their experience in sourcing both raw material and API in China.

4. Navigating China’s Registration Process
In this session, experienced representatives from multi-national and local companies will be available to discuss the registration process for products manufactured in China, import licensing issues for products exported to China and the SFDA’s expedited approval process, commonly called the Green Channel.

5. Pathways for Expedited Product Development
This session will introduce subject matter experts on these various approval pathways, and the expected post-approval burdens industry. Panelists will be from the US, China’s SFDA, and the WHO.

6. Global Trends in the Regulation of Biotech and Biosimilar Products
Audience members will be introduced to subject matter experts from regional regulatory authorities, along with industr y, to discuss the regulation of both innovator and follow-on biotechnology products in the US, Europe, and the Asia-Pacific region.

7. A PEC Regulators Town Hall: Multi-Regional Clinical Trials and Acceptability of Foreign Clinical Data
This session will introduce regulators serving on the APEC Regula tory Harmonization Steering Committee and the work the RHSC is conducting that have had substantial experiences with the conduct of multi-regional trials and the unique opportunities and challenges they present.

Intellectual Property

1. Protecting biotechnology inventions in China, US and Europe
The panel will compare and contrast enablement requirement and claim scope in China and the US, the various protections afforded to plants in these countries (utility, PVP, etc.) and explore the aspects of the Third Patent Law Amendments pertaining to genetic resources requirements in patent a pplica tions.

2. Effective IP Mechanisms for Bringing Biopharmaceuticals to Market— Perspectives from the US and Europe
A panel of experts will explore IP incentives necessary to genera te investment in the research and development of biopharmaceuticals.

3. Patent Enforcement in US and China
A panel of experts from China and the US will overview patent enforcement in the US and China.

Vaccines

1. Conquering the Diseases of Asia through Public-Private Partnerships
In this session local and multi-national companies and government leaders will discuss policy strategies that will leverage new vaccine technologies to conquer important infectious diseases affecting China and other Asian-Pacific countries.

2. Partnering in China: Successful Entry Strategies for Vaccine Companies
Panelists in this session will present their approach for entering or partnering in the Chinese vaccine marketplace.

3. Therapeutic DNA Vaccines: Training the Immune System to Fight Cancer and Chronic Diseases
This session will highlight global advances in the use of DNA technologies to treat complex diseases, such as cancer, Alzheimer’s and other chronic conditions.

4. The Pursuit of an HIV Vaccine: Novel Prophylactic and Therapeutic Approaches
In this session the panelists will present novel platforms, clinical data and approaches for both preventive and thera peutic options and discuss the scientific challenges of developing vaccines to both treat and prevent HIV.

Business Development

1. China: It’s a Big Deal
This session will profile one of the most high-profile China-West collaborations of the past year. The principal dealmakers from both companies will be on hand to discuss the deal’s development and will offer candid advice for companies pursuing China-West collaborations.

2. IPOs—The Boom in China
Investors and other experts on the capital markets in China will convene to discuss IPO boom in China,lessons learned and what this could possibly mean for other healthcare IPOs across the globe.

3. Chinese Start-Ups
CEOs of new Chinese start-ups and venture capitalists seeking to finance new companies in China will convene to discuss the challenges and opportunities posed for starting up in China.

4. Product Distribution in China
Senior executives from large pharma and Chinese companies will discuss the different a pproaches to product distribution in China.

Exhibiting

The BIO China event features an exhibition area where attendees will find vital connections to companies and organizations. The exhibition will be in the Grand Ballroom of the Pudong Shangri-La Hotel on October 12 – 13, 2011.  BIO One-on-One Partnering will also take place in the Grand Ballroom so the exhibition will be well visited by the attendees.

Exhibition Hours & Floor plan (download here) 

Wednesday, October 12
10:30 am – 12:00 pm
1:00 pm – 5:30 pm

Thursday, October 13
9:30 am – 12:30 pm
1:30 am – 4:00 pm

Exhibit Fees - All fees payable in U.S. dollars.

•   Raw Space: $3,000 per 3x3 square meter space
•   Shell Scheme Package Space: $3,500 per 3x3 square meter space (includes Wall Panels, Company Fascia Board, Company Name & Booth Number, Information Counter (1), Bar Stool (1), Waste Basket (1), 100w arm spotlights (3), 500W Socket (1))

Each exhibiting company receives two (2) complimentary Exhibitor/Partnering Conference Badges with each 3x3 raw or shell scheme exhibit package.

Space is limited and on a first-come first-served basis.

If you are interested in your company joining the exhibit area, please download the Exhibit Space Contract and send to biochinaexhibits@bio.org. 

Assistance with Stand Design and Construction

The BIO China Exhibitor Kit will be available in July 2011. The kit will contain the stand builder information.

Any other questions can be directed to biochinaexhibits@bio.org. 

BIO China is supported by

About the Organizers

The Biotechnology Industry Organization
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology
technologies. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnolog y industr y, along with industr y-leading innova tor and partnering meetings held around the world.

Zhangjiang Hi-Tech Park (Z-Park)
Z-Park was established on July 28, 1992 as China’s state-level high-tech industrial development zone. After seventeen years of accumulation and development, Zhangjiang Hi-Tech Park, through providing high value-added products and services with innova tive core technologies to progressively replace the life cycle of traditional industries, represents the revolutionary transformation trend of China’s economic development pa ttern.

Related link: BIO China International Conference (Oct,2011 Shanghai)